Mimedx (MDXG) FCF Margin (2016 - 2025)
Historic FCF Margin for Mimedx (MDXG) over the last 16 years, with Q3 2025 value amounting to 25.62%.
- Mimedx's FCF Margin rose 24800.0% to 25.62% in Q3 2025 from the same period last year, while for Sep 2025 it was 16.98%, marking a year-over-year increase of 7100.0%. This contributed to the annual value of 18.76% for FY2024, which is 85100.0% up from last year.
- Per Mimedx's latest filing, its FCF Margin stood at 25.62% for Q3 2025, which was up 24800.0% from 14.44% recorded in Q2 2025.
- In the past 5 years, Mimedx's FCF Margin ranged from a high of 25.62% in Q3 2025 and a low of 22.53% during Q4 2021
- For the 5-year period, Mimedx's FCF Margin averaged around 5.43%, with its median value being 6.66% (2024).
- In the last 5 years, Mimedx's FCF Margin soared by 251400bps in 2023 and then tumbled by -105900bps in 2025.
- Mimedx's FCF Margin (Quarter) stood at 22.53% in 2021, then soared by 62bps to 8.46% in 2022, then skyrocketed by 220bps to 10.18% in 2023, then skyrocketed by 96bps to 19.93% in 2024, then increased by 29bps to 25.62% in 2025.
- Its FCF Margin stands at 25.62% for Q3 2025, versus 14.44% for Q2 2025 and 5.58% for Q1 2025.